UH Seidman Cancer Center performs new image-guided prostate biopsy

Wednesday, November 09, 2016
CLEVELAND – University Hospitals Seidman Cancer Center physicians are among the first in the country to offer a promising new screening tool to detect prostate cancer – MRI (Magnetic Resonance Imaging) - guided prostate biopsy.  Using sophisticated MRI imaging, the technology enables physicians to better visualize and biopsy cancerous cells within the prostate.
 
Performed inside the MRI gantry, this technology enables physicians to distinguish tumors from healthy tissue. Using the advanced MRI images, they are able to then perform a targeted prostate biopsy.
 
“The in-gantry MRI guided biopsy has the potential to revolutionize prostate cancer detection,” says Vikas Gulani, MD, PhD, Director of Magnetic Resonance Imaging at UH Cleveland Medical Center. “The MRI reveals the specific characteristics that distinguish between normal and diseased tissue. Visualizing the tumor’s location within the prostate enables physicians to more accurately target and biopsy the lesion.”

Download full release


<< Back

You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.